Filing Details

Accession Number:
0000929638-25-000105
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-08 17:20:52
Reporting Period:
2025-01-06
Accepted Time:
2025-01-08 17:20:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1607962 Lifeward Ltd. RWLK Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1871665 Lind Global Fund Ii Lp 444 Madison Avenue
41St Floor
New York NY 10022
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value Nis 1.75 Per Share Disposition 2025-01-06 83,326 $3.01 1,347,780 No 4 S Indirect See Footnote
Ordinary Shares, Par Value Nis 1.75 Per Share Disposition 2025-01-06 298,350 $3.46 1,049,430 No 4 S Indirect See Footnote
Ordinary Shares, Par Value Nis 1.75 Per Share Disposition 2025-01-07 190,734 $1.94 858,696 No 4 S Indirect See Footnote
Ordinary Shares, Par Value Nis 1.75 Per Share Disposition 2025-01-07 700 $2.69 857,996 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares sold ranged from $2.90 to $3.06. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.
  2. Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares sold ranged from $3.065 to $4.06. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.
  3. Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares sold ranged from $1.67 to $2.66. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.
  4. Weighted average purchase price for Ordinary Shares purchased. Actual purchase price for shares sold ranged from $2.67 to $2.72. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each separate price.
  5. Reflects securities held directly by Lind Global Fund II LP. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, and Jeff Easton, the managing member of Lind Global Partners II LLC, may each be deemed to have sole voting and dispositive power with respect to these securities. Each of Lind Global Partners II LLC and Jeff Easton disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.